259 related articles for article (PubMed ID: 34503646)
1. Severe hypertriglyceridemia induced by S-1: Subsequent case series of four patients and further review of the literature.
Saito Y; Takekuma Y; Takeuchi S; Komatsu Y; Sugawara M
Int J Clin Pharmacol Ther; 2021 Dec; 59(12):787-793. PubMed ID: 34503646
[TBL] [Abstract][Full Text] [Related]
2. Hypertriglyceridemia induced by S-1: A novel case report and review of the literature.
Saito Y; Takekuma Y; Komatsu Y; Sugawara M
J Oncol Pharm Pract; 2021 Jun; 27(4):1020-1025. PubMed ID: 32936722
[TBL] [Abstract][Full Text] [Related]
3. Hypertriglyceridemia Induced by Fluorouracil: A Novel Case Report.
Saito Y; Takekuma Y; Yuki S; Komatsu Y; Sugawara M
Case Rep Oncol; 2021; 14(1):207-211. PubMed ID: 33776705
[TBL] [Abstract][Full Text] [Related]
4. Safety of alternate-day treatment with TS-1
Nishiyama Y; Fukuyama Y; Maruo T; Yoda S; Iwano M; Kawarai S; Kayanuma H; Orito K
J Vet Med Sci; 2021 Aug; 83(8):1206-1211. PubMed ID: 34148911
[TBL] [Abstract][Full Text] [Related]
5. Fluoropyridmidine use and hypertriglyceridemia among Japanese patients: analysis of adverse event database.
Mitsuboshi S; Niimura T; Yoshino M; Sakamoto Y; Zamami Y; Ishizawa K
Int J Clin Pharm; 2022 Feb; 44(1):260-263. PubMed ID: 34482500
[TBL] [Abstract][Full Text] [Related]
6. S-1-Associated Hypertriglyceridemia in a Patient With Pancreatic Adenocarcinoma.
Chen HW; Kuo HY; Chen BB; Tien YW; Kuo SH; Yang SH
JCO Oncol Pract; 2020 Jan; 16(1):45-47. PubMed ID: 31618087
[No Abstract] [Full Text] [Related]
7. The first case of phenytoin intoxication associated with the concomitant use of phenytoin and TS-1, a combination preparation of tegafur, gimeracil, and oteracil potassium.
Tsuda A; Fujiyama J; Miki A; Hori S; Ohtani H; Sawada Y
Cancer Chemother Pharmacol; 2008 Aug; 62(3):427-32. PubMed ID: 18026730
[TBL] [Abstract][Full Text] [Related]
8. The Clinical Evaluation of Tegafur Gimeracil Oteracil Combined with THP and DDP for Second-Line Treatment of Advanced Cardiac Carcinoma.
Wang HF; Lv JQ
Cell Biochem Biophys; 2015 Jul; 72(3):695-9. PubMed ID: 25618173
[TBL] [Abstract][Full Text] [Related]
9. Case report: hand-foot syndrome induced by the oral fluoropyrimidine S-1.
Elasmar SA; Saad ED; Hoff PM
Jpn J Clin Oncol; 2001 Apr; 31(4):172-4. PubMed ID: 11386466
[TBL] [Abstract][Full Text] [Related]
10. Capecitabine-induced severe hypertriglyceridemia: report of two cases.
Kurt M; Babaoglu MO; Yasar U; Shorbagi A; Guler N
Ann Pharmacother; 2006 Feb; 40(2):328-31. PubMed ID: 16391007
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of S-1 (tegafur, gimeracil, and oteracil potassium) concurrent with 3-dimensional conformal radiotherapy for newly diagnosed squamous cell carcinoma of the lung in elderly patients.
Wang T; Zhang SF; Qiu MQ; Li QL
Cancer Radiother; 2016 May; 20(3):181-6. PubMed ID: 27068497
[TBL] [Abstract][Full Text] [Related]
12. Feasibility study of adjuvant chemotherapy with S-1 (TS-1; tegafur, gimeracil, oteracil potassium) for gastric cancer.
Kinoshita T; Nashimoto A; Yamamura Y; Okamura T; Sasako M; Sakamoto J; Kojima H; Hiratsuka M; Arai K; Sairenji M; Fukushima N; Kimura H; Nakajima T
Gastric Cancer; 2004; 7(2):104-9. PubMed ID: 15224197
[TBL] [Abstract][Full Text] [Related]
13. [Antitumor activity and function of S-1, a new oral tegafur-based formulation].
Fukushima M
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():19-26. PubMed ID: 16897968
[TBL] [Abstract][Full Text] [Related]
14. Hypertriglyceridemia and hyperglycemia induced by capecitabine: a report of two cases and review of the literature.
Han GH; Huang JX
J Oncol Pharm Pract; 2015 Oct; 21(5):380-3. PubMed ID: 24781450
[TBL] [Abstract][Full Text] [Related]
15. Phase I and pharmacokinetic study of the oral fluoropyrimidine S-1 on a once-daily-for-28-day schedule in patients with advanced malignancies.
Chu QS; Hammond LA; Schwartz G; Ochoa L; Rha SY; Denis L; Molpus K; Roedig B; Letrent SP; Damle B; DeCillis AP; Rowinsky EK
Clin Cancer Res; 2004 Aug; 10(15):4913-21. PubMed ID: 15297391
[TBL] [Abstract][Full Text] [Related]
16. [Tegafur gimeracil oteracil potassium capsule induced acute interstitial lung disease: a case report].
Li F; Ju Y; Guan Y; Zhao H
Zhongguo Fei Ai Za Zhi; 2014 Jan; 17(1):53-6. PubMed ID: 24398315
[No Abstract] [Full Text] [Related]
17. Combination of gemfibrozil and orlistat for treatment of combined hyperlipidemia with predominant hypertriglyceridemia.
Tolentino MC; Ferenczi A; Ronen L; Poretsky L
Endocr Pract; 2002; 8(3):208-12. PubMed ID: 12113634
[TBL] [Abstract][Full Text] [Related]
18. Tegafur + gimeracil + oteracil. Just another fluorouracil precursor.
Prescrire Int; 2013 May; 22(138):122. PubMed ID: 23819172
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of the efficacy and safety of capecitabine or tegafur, gimeracil and oteracil potassium capsules combined with oxaliplatin chemotherapy regimens in the treatment of advanced gastric cancer].
Wan Y; Hui H; Wang X; Wu J; Sun S
Zhonghua Zhong Liu Za Zhi; 2016 Jan; 38(1):28-34. PubMed ID: 26796803
[TBL] [Abstract][Full Text] [Related]
20. The European Medicines Agency review of Tegafur/Gimeracil/Oteracil (Teysuno™) for the treatment of advanced gastric cancer when given in combination with cisplatin: summary of the Scientific Assessment of the Committee for medicinal products for human use (CHMP).
Matt P; van Zwieten-Boot B; Calvo Rojas G; Ter Hofstede H; Garcia-Carbonero R; Camarero J; Abadie E; Pignatti F
Oncologist; 2011; 16(10):1451-7. PubMed ID: 21963999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
